We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HYL market cap is 166.88M. The company's latest EPS is EUR -0.5629 and P/E is -10.59.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 91k | 175k | 3.1M | 2.95M | 4.41M |
Operating Income | -5.27M | -7.05M | -10.54M | -10.64M | -16.24M |
Net Income | -5.37M | -7.15M | -11.58M | -10.77M | -15.76M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 5.98M | 69.18M | 63.44M | 61.86M | 47.61M |
Total Liabilities | 16.17M | 10.12M | 15.39M | 6.82M | 8.79M |
Total Equity | -10.19M | 59.06M | 48.06M | 55.05M | 38.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -4.56M | -4.57M | -11.25M | -13.15M | -12.73M |
Investing | -1.23M | -633k | -3.08M | -1.24M | 9.65M |
Financing | 3.31M | 69.4M | -62k | 7.84M | -188k |
Market Cap | 166.88M |
Price to Earnings Ratio | -10.59 |
Price to Sales Ratio | 37.87 |
Price to Cash Ratio | 5.53 |
Price to Book Ratio | 4.3 |
Dividend Yield | - |
Shares Outstanding | 28M |
Average Volume (1 week) | 8.28k |
Average Volume (1 Month) | 10.44k |
52 Week Change | -52.32% |
52 Week High | 14.10 |
52 Week Low | 2.89 |
Spread (Intraday) | 0.14 (2.3%) |
Company Name | Hyloris Pharmaceuticals SA |
Address |
boulevard patience et beaujonc liege, liege 4000 |
Website | https://www.hyloris.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions